Literature DB >> 12091380

The role of ADAM 15 in glomerular mesangial cell migration.

John Martin1, Lisa V Eynstone, Malcolm Davies, John D Williams, Robert Steadman.   

Abstract

Mesangial cells (MC) occupy the core of the renal glomerulus and are surrounded by a mesangial matrix. In certain diseases, MC migrate through this matrix into the pericapillary space. The mechanisms involved, however, are poorly understood. Members of the ADAM (A Disintegrin And Metalloproteinase) family of membrane proteins have the potential to be key modulators of cell-matrix interactions through the activities of their constituent domains. We have studied the possible role of ADAM 15 in human (H) MC migration in vitro. HMC ADAM 15 was expressed at low levels in serum-free medium but was increased during migration. Antibodies to the individual domains of ADAM 15 and the incorporation of antisense ADAM 15, (but not control oligonucleotide) inhibited this migration. Furthermore, inhibition of migration by the broad spectrum metalloproteinase inhibitor BB3103, demonstrated that metalloproteinase activity was essential for migration. ADAM 15, extracted from HMC membranes, was an active metalloproteinase, which degraded both type IV collagen and gelatin prepared from fibrillar collagen. Activity was inhibited by EDTA but not by phenylmethylsulfonyl fluoride. This is the first report of the potential of ADAM 15 for involvement in the restructuring of the mesangial matrix and in the migration of MC in disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091380     DOI: 10.1074/jbc.M200988200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.

Authors:  Takayuki Shiomi; Vincent Lemaître; Jeanine D'Armiento; Yasunori Okada
Journal:  Pathol Int       Date:  2010-07       Impact factor: 2.534

2.  ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.

Authors:  Rainer Kuefer; Kathleen C Day; Celina G Kleer; Michael S Sabel; Matthias D Hofer; Sooryanarayana Varambally; Christoph S Zorn; Arul M Chinnaiyan; Mark A Rubin; Mark L Day
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

3.  Selective modulation of integrin-mediated cell migration by distinct ADAM family members.

Authors:  Jing Huang; Lance C Bridges; Judith M White
Journal:  Mol Biol Cell       Date:  2005-08-03       Impact factor: 4.138

4.  ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.

Authors:  Thomas Tousseyn; Amantha Thathiah; Ellen Jorissen; Tim Raemaekers; Uwe Konietzko; Karina Reiss; Elke Maes; An Snellinx; Lutgarde Serneels; Omar Nyabi; Wim Annaert; Paul Saftig; Dieter Hartmann; Bart De Strooper
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

Review 5.  Anchoring junctions as drug targets: role in contraceptive development.

Authors:  Dolores D Mruk; Bruno Silvestrini; C Yan Cheng
Journal:  Pharmacol Rev       Date:  2008-05-15       Impact factor: 25.468

6.  The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation.

Authors:  Abdo J Najy; Kathleen C Day; Mark L Day
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

7.  Expression of ADAM-15 in rat myocardial infarction.

Authors:  Ji Ke Li; Wen Juan Du; Shu Lin Jiang; Hai Tian
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

8.  ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury.

Authors:  Robin Roychaudhuri; Anja H Hergrueter; Francesca Polverino; Maria E Laucho-Contreras; Kushagra Gupta; Niels Borregaard; Caroline A Owen
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

9.  Expression of ADAM15 in lung carcinomas.

Authors:  A Schütz; W Härtig; M Wobus; J Grosche; Ch Wittekind; G Aust
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

10.  A disintegrin and metalloproteinase 15 contributes to atherosclerosis by mediating endothelial barrier dysfunction via Src family kinase activity.

Authors:  Chongxiu Sun; Mack H Wu; Eugene S Lee; Sarah Y Yuan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-16       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.